Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., Georgoulias, V.
Published in Annals of oncology (01.07.2015)
Published in Annals of oncology (01.07.2015)
Get full text
Journal Article
Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
Kallergi, G, Aggouraki, D, Zacharopoulou, N, Stournaras, C, Georgoulias, V, Martin, S S
Published in Breast cancer research : BCR (05.07.2018)
Published in Breast cancer research : BCR (05.07.2018)
Get full text
Journal Article
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
Georgoulias, V., Bozionelou, V., Agelaki, S., Perraki, M., Apostolaki, S., Kallergi, G., Kalbakis, K., Xyrafas, A., Mavroudis, D.
Published in Annals of oncology (01.07.2012)
Published in Annals of oncology (01.07.2012)
Get full text
Journal Article
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Van Cutsem, E., Rivera, F., Berry, S., Kretzschmar, A., Michael, M., DiBartolomeo, M., Mazier, M.-A., Canon, J.-L., Georgoulias, V., Peeters, M., Bridgewater, J., Cunningham, D.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project
Souglakos, J., Boukovinas, I., Kakolyris, S., Xynogalos, S., Ziras, N., Athanasiadis, A., Androulakis, N., Christopoulou, A., Vaslamatzis, M., Ardavanis, A., Emmanouilides, C., Bompolaki, I., Kourousis, C., Makrantonakis, P., Christofyllakis, C., Athanasiadis, E., Kentepozidis, N., Karampeazis, A., Katopodi, U., Anagnosopoulos, A., Papadopoulos, G., Prinarakis, E., Kalisperi, A., Mavroudis, D., Georgoulias, V.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer
Markou, A N, Londra, D, Stergiopoulou, D, Vamvakaris, I, Potaris, K, Pateras, I S, Kotsakis, A, Georgoulias, V, Lianidou, E
Published in Cancers (01.03.2023)
Published in Cancers (01.03.2023)
Get full text
Journal Article
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome
Saridaki, Z, Papadatos-Pastos, D, Tzardi, M, Mavroudis, D, Bairaktari, E, Arvanity, H, Stathopoulos, E, Georgoulias, V, Souglakos, J
Published in British journal of cancer (08.06.2010)
Published in British journal of cancer (08.06.2010)
Get full text
Journal Article
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
SOUGLAKOS, J, PHILIPS, J, FREED, E, MEYERHARDT, J. A, SARIDAKI, Z, GEORGOULIAS, V, FINKELSTEIN, D, FUCHS, C. S, KULKE, M. H, SHIVDASANI, R. A, WANG, R, MARWAH, S, SILVER, M, TZARDI, M, SILVER, J, OGINO, S, HOOSHMAND, S, KWAK, E
Published in British journal of cancer (04.08.2009)
Published in British journal of cancer (04.08.2009)
Get full text
Journal Article
Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
Valachis, A, Polyzos, N. P, Patsopoulos, N. Α, Georgoulias, V, Mavroudis, D, Mauri, D
Published in Breast cancer research and treatment (01.07.2010)
Published in Breast cancer research and treatment (01.07.2010)
Get full text
Journal Article
Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group
Koinis, F, Agelaki, S, Karavassilis, V, Kentepozidis, N, Samantas, E, Peroukidis, S, Katsaounis, P, Hartabilas, E, Varthalitis, I I, Messaritakis, I, Fountzilas, G, Georgoulias, V, Kotsakis, A
Published in British journal of cancer (27.06.2017)
Published in British journal of cancer (27.06.2017)
Get full text
Journal Article
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
Souglakos, J, Androulakis, N, Syrigos, K, Polyzos, A, Ziras, N, Athanasiadis, A, Kakolyris, S, Tsousis, S, Kouroussis, Ch, Vamvakas, L, Kalykaki, A, Samonis, G, Mavroudis, D, Georgoulias, V
Published in British journal of cancer (27.03.2006)
Published in British journal of cancer (27.03.2006)
Get full text
Journal Article
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
BALGKOURANIDOU, I, CHIMONIDOU, M, MILAKI, G, TSAROUXA, E. G, KAKOLYRIS, S, WELCH, D. R, GEORGOULIAS, V, LIANIDOU, E. S
Published in British journal of cancer (15.04.2014)
Published in British journal of cancer (15.04.2014)
Get full text
Journal Article
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
PAPADAKI, C, SFAKIANAKI, M, GEORGOULIAS, V, SOUGLAKOS, J, LAGOUDAKI, E, GIAGKAS, G, IOANNIDIS, G, TRYPAKI, M, TSAKALAKI, E, VOUTSINA, A, KOUTSOPOULOS, A, MAVROUDIS, D
Published in British journal of cancer (28.10.2014)
Published in British journal of cancer (28.10.2014)
Get full text
Journal Article
Evaluation of Monocarboxylate Transporter 4 ( MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer
Markou, Athina, Tzanikou, E, Kallergi, G, Pantazaka, E, Georgoulias, V, Kotsakis, A, Lianidou, E
Published in Frontiers in cell and developmental biology (22.04.2021)
Published in Frontiers in cell and developmental biology (22.04.2021)
Get full text
Journal Article
Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333–1340
Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., Georgoulias, V.
Published in Annals of oncology (01.03.2020)
Published in Annals of oncology (01.03.2020)
Get full text
Journal Article
Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history
Gioulbasanis, I., Baracos, V.E., Giannousi, Z., Xyrafas, A., Martin, L., Georgoulias, V., Mavroudis, D.
Published in Annals of oncology (01.04.2011)
Published in Annals of oncology (01.04.2011)
Get full text
Journal Article
Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib
Messaritakis, I, Politaki, E, Plataki, M, Karavassilis, V, Kentepozidis, N, Koinis, F, Samantas, E, Georgoulias, V, Kotsakis, A
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2017)
Get full text
Journal Article